Aardvark Therapeutics, Inc. (AARD)
NASDAQ: AARD · Real-Time Price · USD
15.01
-0.07 (-0.46%)
At close: Jan 23, 2026, 4:00 PM EST
15.31
+0.30 (2.00%)
After-hours: Jan 23, 2026, 6:52 PM EST
Aardvark Therapeutics Market Cap
Aardvark Therapeutics has a market cap or net worth of $326.82 million as of January 23, 2026.
Market Cap
326.82M
Enterprise Value
201.01M
1-Year Change
n/a
Ranking
Category
Stock Price
$15.01
Market Cap Chart
Since the IPO on February 13, 2025, Aardvark Therapeutics's market cap has decreased from $342.15M to $326.82M, a decrease of -4.48%. That is a compound annual growth rate of -4.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 326.82M | 14.36% |
| Dec 31, 2025 | 285.77M | -16.48% |
| Feb 13, 2025 | 342.15M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Candel Therapeutics | 345.86M |
| Puma Biotechnology | 345.68M |
| Immuneering | 344.80M |
| XOMA Royalty | 333.35M |
| X4 Pharmaceuticals | 328.76M |
| Greenwich LifeSciences | 326.41M |
| Fractyl Health | 317.48M |
| Protara Therapeutics | 316.70M |